Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on MTOR Gene Mutation in Finland
Total 0 results
Nothing found
Sponsors and Collaborators
IRCCS Istituto Auxologico Italiano, Milano, Italy
Sahachat Aueyingsak
Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
Sublimity Therapeutics Holdco Limited
Dr Philippe METELLUS
Daniela Pacella - University of Naples Federico II, Naples
National Institute of Cardiovascular Diseases, Bangladesh
ECMC
AlpinARC
Glasgow Western Infirmary
the people hospital of Linzhi
The Australia-Israel Scientific Exchange Foundation (AISEF)
Etan Orgel
Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
Centro Universitário Franciscano
Bassam Abdulkarim
ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
Hospitales Universitarios Virgen del Rocío
Åke Wibergs Stiftelse
View Full List
Medical Conditions
Hyperprolinemia
Value-Based Health Insurance
Progression to PD-1 Antibody
Patients With Leptomeningeal Disease
Genetic Risk Factor
Ability to Swim 100m Independent Freestyle
Degenerative Spondylolisthesis G1
Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
Eosinophil Blood Count
Orthopaedic Disorders
Initiation of Depo-Provera (DMPA)
Very Long Chain Acyl Coa Dehydrogenase Deficiency
Panniculectomy
Pancreaticoduodenectomy
Adult Patients Undergoing Surgery That Requires General Anesthesia
Legal History
Interviews
Bladder Cancer TNM Staging Primary Tumor (T) T2B
Transitional Cell Carcinoma of Renal Pelvis
View Full List
Drug Interventions
5-Fluoro-uracil
Epirubicin hydrochloride
Nimotuzumab
IV rtPA (intravenous recombinant plasminogen activator)
Omeprazole 20mg
Injectable Insulin
Prasugrel
Paliperidone palmitate
ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
ASP8062
0% N2O
HBM4003 and Triprilimab
Gefitinib
Metoclopramide + dexamethasone
UFUR and Iressa
Erythropoietin
Cefuroxime 750mg oral
Mepivacaine
6% hetastarch
Antibiotic treatment
View Full List
CROs by country
Contract Research Organizations in Bahrain
Contract Research Organizations in Belarus
Contract Research Organizations in Finland
Contract Research Organizations in Gambia
Contract Research Organizations in Hong Kong
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Luxembourg
Contract Research Organizations in Macedonia
Contract Research Organizations in Malaysia
Contract Research Organizations in Mauritania
Contract Research Organizations in Romania
Contract Research Organizations in Thailand
Contract Research Organizations in Turkmenistan
CRO list by country
CROs in Malawi
SGS
All CROs in Malawi
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe